Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-Deoxy-2-[F-18]fluoro-D-glucose-Positron emission tomography

Molecular Imaging and Biology

Volumn 9, Issue 5, 2007, Pages 300-307

  Fan, Chengzhong ^a,c   Hernandez Pampaloni, Miguel ^a   Houseni, Mohamed ^a   Chamroonrat, Wichana ^a   Basu, Sandip ^a   Kumar, Rakesh ^a   Dadparvar, Simin ^a   Torigian, Drew A ^b   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Aging; Bone marrow; Fluorine 18 fluorodeoxyglucose; Function; Metabolism; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW DISEASE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; FEMALE; FEMUR; HUMAN; HUMERUS; LABORATORY TEST; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOGRAPHY; RETROSPECTIVE STUDY; SEX RATIO; STATISTICAL SIGNIFICANCE; STERNUM; THORACIC SPINE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 34548171706     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-007-0100-9     Document Type: Article

References (42)

1. Zhao P, Liu W, Cui Y (2006) Rapid immune reconstitution and dendritic cell engraftment post-bone marrow transplantation with heterogeneous progenitors and GM-CSF treatment. Exp Hematol 34:951-964, Jul
2. Zhang Y, Adachi Y, Iwasaki M, Minamino K, Suzuki Y, Nakano K, Koike Y, Mukaide H, Shigematsu A, Kiriyama N, Li C, Ikehara S (2006) G-CSF and/or M-CSF accelerate differentiation of bone marrow cells into endothelial progenitor cells in vitro. Oncol Rep 15:1523-1527, Jun
3. Gazitt Y, Akay C, Thomas C 3rd (2006) No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-Hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF. Stem Cells Dev 15:269-277, Apr
4. Johnston KL, Farnen JP, Manske BR, Go RS (2005) Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors. Haematologica 90(12 Suppl), Dec
5. Blodgett TM, Ames JT, Torok FS, McCook BM, Meltzer CC (2004) Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med 29:161-163, Mar
6. Brynes RK, McKenna RW, Sundberg RD (1978) Bone marrow aspiration and trephine biopsy: An approach to a thorough study. Am J Clin Pathol 70:753-759, Nov
7. Ellis LD, Jensen JN, Westerman MF (1964) Needle biopsy of bone and marrow: An experience with 1,445 biopsies. Arch Intern Med 114:213-214
8. James LP, Stass SA, Schumacher HR (1980) Value of imprint preparations of bone marrow biopsies in hematologic diagnosis. Cancer 46:173-177, Jul 1
9. Jamshidi K, Swaim WR (1971) Bone marrow biopsy with unaltered architecture: A new biopsy device. J Lab Clin Med 77:335-342, Feb
10. Knowles S, Hoffbrand AV (1980) Bone-marrow aspiration and trephine biopsy (1). Br Med J 281:204-205, Jul 19
11. Steiner RM, Mitchell DG, Rao VM, et al. (1993) Magnetic resonance imaging of diffuse bone marrow disease. Radiol Clin North Am 31:383-409
12. Federico M, Magin RL, Swartz HM, et al. (1989) Detection of bone marrow involvement in patients with cancer. Tumori 75:90-96
13. Alavi A, Kung JW, Zhuang H (2004) Implications of PET based molecular imaging on the current and future practice of medicine. Semin Nucl Med 34:56-69
14. Belhocine T, Spaepen K, Dusart M, Castaigne C, Muylle K, Bourgeois P, Bourgeois D, Dierickx L, Flamen P (2006) 18FDG-PET in oncology: The best and the worst. Int J Oncol 28:1249-1261, May
15. Kumar R, Nadig MR, Chauhan A (2005) Positron emission tomography: clinical applications in oncology. Part 1. Expert Rev Anticancer Ther (6):1079-1094, Dec 5
16. Wechalekar K, Sharma B, Cook G (2005) PET/CT in oncology - a major advance. Clin Radiol 60:1143-1155, Nov
17. Kazama T, Swanston N, Podoloff DA, Macapinlac HA (2005) Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging 32:1406-1411, Dec. Epub 2005 Aug 31
18. Meyer MA, Nathan CA (2000) Reduced F-18 fluorodeoxyglucose uptake within marrow after external beam radiation. Clin Nucl Med 25:279-280, Apr
19. Kricun ME (1985) Red-yellow marrow conversion: Its effect on the location of some solitary bone lesions. Skeletal Radiol 14:10-19
20. Hashimoto M (1962) Pathology of bone marrow. Acta Haematol 27:193-216
21. Dunnhill MS, Anderson JH, Whitehead R (1967) Quantitative histological studies on age changes in bone. J Pathol Bacteriol 94:275-291
22. Vogler JB 3rd, Murphy WA (1988) Bone marrow imaging. Radiology 168:679-693
23. Desai AG, Thakur ML (1985) Radiopharmaceuticals for spleen and bone marrow studies. Semin Nucl Med 15:229-238
24. Datz FL, Taylor A Jr (1985) The clinical use of radionuclide bone marrow imaging. Semin Nucl Med 15:239-259
25. Engstedt L, Franzen S, Jonsson L, et al. (1958) In vivo localization of colloidal Au198 intravenously injected in polycythemia vera: A preliminary report. Acta Radiol 49:66-71
26. Silberstein B (1998) Nuclear hematology: The erythron. In: Nucl Med Annual 163-174
27. Kim C, Reske S.N, Abass Alavi (1996) Bone marrow scintigraphy. In: Henkin R., et al. (eds) Nuclear medicine. By Mosby-Year book, pp 1223-1224
28. Herbert CJ, et al (eds). (1996) Nuclear medicine: Diagnosis and therapy. New York, NY: By Thieme medical Publishers, Inc., pp 780-784
29. Van Dyke D, Price D, Shkurkin C, et al. (1967) Differences in distribution of erythropoietic and reticuloendothelial marrow in hematologic disease. Blood 30:364-374
30. Hotze A, Low A, Mahlstedt J, et al. (1984) Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases. Rofo 140:717-723
31. Blend MJ, Pavel DG (1986) Bone marrow imaging: A comparison study using a 99m Tc-sulphur colloid versus a new 99m Tc microaggregated albumin. Nucl Med Commun 7:787-789
32. Beamish MR, Brown EB (1974) The metabolism of transferrin-bound 111In and 59Fe in the rat. Blood 43:693-701
33. Bourgeois P, Demonceau G, Stegen M, et al. (1991) 99Tcm-HMPAO-labelled leucocytes for bone marrow scintigraphy and evaluation of skeletal lesions: Comparison with 99Tcm-HSA colloid results. Nucl Med Commun 12:621-627
34. Duncker CM, Carrio I, Berna L, et al. (1990) Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med 31:1450-1455
35. Munz DL, Sandrock D, Rilinger N (1990) Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow. Lancet 336:258-259
36. Reske SN, Buell U (1990) Reduced technetium 99m labelled NCA-95/ CEA-antibody uptake in liver due to gentle antibody reconstitution: technical note. Eur J Nucl Med 17:38-41
37. Reske SN, Karstens JH, Gloeckner W, et al. (1989) Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1:299-301
38. Alavi A, Lakhani P, Mavi A, et al. (2004) PET: A revolution in medical imaging. Radiol Clin North Am 42:983-1001
39. Cheran SK, Herndon JE 2nd, Patz EF Jr (2004) Comparison of whole-body FDG to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 44:317-325
40. Durski JM, Srinivas S, Segall G (2000) Comparison of GDF-PET and bone scans for detecting skeletal metastases in patients with non-small cell lung cancer. Clin Positron Imaging 3:97-105
41. El-Haddad G, Zhuang H, Gupta N, et al. (2004) Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med 34:313-329
42. Shreve PD, Anzai Y, Wahl RL (1999) Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics 19:61-77